CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Down 98.0% in November

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) saw a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 100 shares, a decrease of 98.0% from the November 15th total of 4,900 shares. Based on an average daily volume of 34,700 shares, the short-interest ratio is presently 0.0 days.

CSPC Pharmaceutical Group Stock Performance

CSPCY stock traded down C$0.05 during trading hours on Friday, hitting C$2.47. The company’s stock had a trading volume of 110,071 shares, compared to its average volume of 40,522. CSPC Pharmaceutical Group has a 12 month low of C$2.25 and a 12 month high of C$3.82. The stock has a 50 day moving average price of C$2.88 and a two-hundred day moving average price of C$2.91.

CSPC Pharmaceutical Group Increases Dividend

The firm also recently announced a dividend, which was paid on Thursday, December 5th. Stockholders of record on Friday, November 1st were issued a dividend of $0.0575 per share. The ex-dividend date was Friday, November 1st. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.